4
Changes in Ownership
Arcutis Biotherapeutics, Inc. Filed Acc 0001628280-26-014639
Director sold 10,000 shares at $25.65 ($256,518)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Welgus Howard G. · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-02 | Sale : show line 1 in the form 10b5-1 | −10,000 | $25.65 | $256,518 | 49,744 | D |
| Open-market sales · 10,000 sh · avg $25.65 · $256,518 | ||||||
Loading xslF345X05/wk-form4_1772658986.xml…